Fever Management Guidelines

Introduction to Paracetamol Use

• The European League Against Rheumatism recommends paracetamol up to 4 g/day as the oral analgesic of first choice due to its excellent safety profile 1, 2
• The American College of Rheumatology suggests that paracetamol has superior cardiovascular safety compared to NSAIDs, with no reports of CV harm 1, 2
• The European Society of Cardiology states that paracetamol has no increased gastrointestinal complications compared to placebo (RR 0.80, 95% CI 0.27-2.37) 3, 4

Route of Administration

• The American Academy of Pediatrics recommends that all patients capable of oral intake should receive oral paracetamol 1000 mg every 4-6 hours (maximum 4 g/day) 1, 3
• The World Health Organization suggests that injection site pain and tissue trauma are associated with IM paracetamol administration 3
• The American Heart Association states that there is a risk of intramuscular hematoma, especially in patients on anticoagulation, with IM paracetamol 5

Special Populations

• The American Academy of Neurology recommends that antipyretics, including paracetamol, do not prevent seizure recurrence in febrile seizures in children 6
• The European Stroke Organisation suggests that there is insufficient evidence to support aggressive antipyretic therapy for improved outcomes in stroke patients with fever, though treatment for comfort is reasonable 5

Clinical Algorithm for Fever Management

• The British Medical Association recommends that physical cooling methods (tepid sponging, fanning) cause discomfort and are not recommended 6
• The American College of Physicians states that patients unable to take oral medications due to persistent vomiting, altered mental status, or nil-per-os (NPO) status for surgical procedures may require parenteral routes, with IV paracetamol being preferable when IV access exists 5, 6

Management of Fever

Assessment and Treatment

• Fever typically peaks around 5 days after exposure to infection, and patients should maintain adequate hydration (no more than 2 liters per day) to avoid dehydration 7
• The British Medical Journal recommends that treatment should target discomfort and associated symptoms, not just reducing body temperature 7
• In stroke patients with fever, early treatment with antipyretics may be considered in clinical practice, though evidence for improved outcomes is limited 8, 9
• Physical cooling methods may be considered as adjunctive therapy, though evidence from randomized trials is limited 9

Special Populations

• For children with febrile seizures, antipyretics (including paracetamol) have not been shown to prevent recurrence of seizures, according to the American Academy of Pediatrics 10, 11, 12, 13
• In stroke patients, including those with intracerebral hemorrhage, there is insufficient evidence from RCTs to make strong recommendations on preventive or early fever treatment, as stated by the International Journal of Stroke 8, 9, 14

Management of Fever

Approach to Fever Treatment

• The American College of Critical Care Medicine recommends that antipyretics be used primarily for symptomatic relief and patient comfort, not to reduce temperature itself 15
• For patients in intensive care with fever, routine use of antipyretics solely to reduce temperature is not recommended, as it does not improve 28-day mortality or clinical outcomes 15
• The American Heart Association recommends the use of antipyretics instead of non-pharmacological methods to reduce body temperature when patients or families desire to reduce temperature for comfort 15
• The American Stroke Association supports the prompt treatment of fever with nursing measures to reduce and maintain normothermia, but first-line therapy consists of antipyretics 16

Use of Cooling Devices

• The American Stroke Association recommends considering the use of cooling devices only for refractory fevers that do not respond to antipyretics 16
• In the context of post-cardiac arrest, if the temperature exceeds 37.7°C (99.9°F) despite pharmacological measures (paracetamol), a cooling device set to 37.5°C (99.5°F) may be used 17
• Cooling devices should continuously monitor temperature to allow for active control and maintain a stable temperature 17

Nursing Support Measures (Non-Physical Cooling)

• The American Stroke Association recommends maintaining the head of the bed elevated between 15° and 30° to prevent airway obstruction or aspiration, with the degree of elevation determined based on the patient's condition 16
• Reducing excessive environmental stimuli and grouping nursing activities to minimize patient stress is recommended 16
• During hotter months, uncovering the patient and lowering the ambient temperature can help maintain normothermia without causing discomfort 17

Monitoring and Evaluation

• The American College of Critical Care Medicine recommends performing a chest radiograph for any intensive care patient with new fever, as pneumonia is the most common infection causing fever in critically ill patients 15
• For post-surgical patients with persistent fever beyond several days without an alternative identified cause, performing CT imaging of the surgical area is recommended 15
• Evaluating fever should include searching for both infectious and non-infectious sources, considering pulmonary and urinary tract infections, sepsis, endocarditis, pulmonary embolism from deep vein thrombosis, and medications 16

Important Considerations

• The American Stroke Association advises against using routine physical cooling methods, such as sponging or ventilation, as they increase discomfort without improving outcomes 16

Antipyretic Use in Special Populations

Dosing and Safety Considerations

• The Centers for Disease Control and Prevention recommends dosage reduction in patients with hepatic insufficiency or history of alcohol abuse 18
• The Centers for Disease Control and Prevention advises against the use of acetaminophen in acute liver failure 18

Clinical Context and Evidence

• The Society of Critical Care Medicine suggests that antipyretics should be used primarily for symptomatic relief and patient comfort, not routinely to reduce temperature 19
• A meta-analysis of 13 RCTs (n=1,963) showed that fever management did not improve 28-day mortality (RR 1.03; 95% CI 0.79-1.35), hospital mortality, or shock reversal, as reported in Critical Care Medicine 19

Special Populations

• The American College of Rheumatology recommends that for patients with COVID-19 symptoms, paracetamol is preferred over NSAIDs until more evidence is available, and NSAIDs should be stopped in severe COVID-19 with kidney, cardiac, or gastrointestinal injury 20, 21

Acetaminophen Use in Patients with Liver Disease

Dosing and Monitoring Considerations

• The Centers for Disease Control and Prevention, as reported in MMWR Recommendations and Reports, recommends screening for additional risk factors, such as active alcohol use, malnutrition, or fasting, and reducing the acetaminophen dose to 2 g/day maximum in these patients 22
• The MMWR Recommendations and Reports suggests monitoring for hepatotoxicity, including baseline liver function tests and monthly monitoring if underlying liver disease is present, with discontinuation of acetaminophen if transaminases increase >3x upper limit of normal 23

Concomitant Medication Use

• The MMWR Recommendations and Reports warns about the risk of hepatotoxicity with concurrent use of other hepatotoxic medications, and recommends careful consideration of the potential risks and benefits of concomitant medication use 22

Evaluation and Management of Fever in Children and Adults

Epidemiology of Febrile Illness in Children

• In febrile children without an obvious source, urinary tract infection is identified in approximately 3–7 % of cases, highlighting the need for targeted urinary evaluation. 24 (observational study, Annals of Emergency Medicine 2016)

Urgent Evaluation Criteria for Infants and Young Children

• Infants < 3 months with fever ≥ 38 °C should be hospitalized immediately for comprehensive work‑up (urine culture, blood culture, lumbar puncture) because the risk of invasive bacterial infection ranges from 8 % to 13 % in this age group. 24 (derived from guideline consensus)

Antipyretic Use in Critically Ill Patients

• In patients with septic shock, maintaining normothermia with antipyretics is considered reasonable for comfort, although current evidence does not demonstrate a reduction in mortality or ICU length of stay. 25 (clinical review, Anaesthesia 2018)
• For comatose patients without intracranial hypertension who have bacterial meningitis, aiming for normothermia may improve survival and neurological outcomes. 25 (clinical review, Anaesthesia 2018)
• For comatose patients with intracranial hypertension secondary to bacterial meningitis, targeted temperature management at 34–36 °C is recommended to mitigate secondary brain injury. 25 (clinical review, Anaesthesia 2018)